News
Rare, deadly, and often missed, some skin cancers develop in areas that rarely see the sun. Scientists are still learning about them, but here's what we know.
A painful sore throat is a signature symptom of an Omicron subvariant called NB.1.8.1, or Nimbus. It now makes up about a third of U.S. COVID-19 cases. Find out what you can do to get relief.
Living with bipolar disorder isn’t just about mood swings: it’s about carrying an invisible weight that few people understand.
What’s the most overrated strategy for protecting your brain? And what’s the one you should actually be using?
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...
The “blue waffle” hoax is a made-up sexually transmitted infection (STI) affecting women. Here’s how to fact check online health information and avoid scams.
A new report questions the safety and effectiveness of most sunscreens, but dermatologists say those concerns may be overblown and must be weighed against skin cancer risk.
If one thing’s for sure, it’s that there’s always another coffee study, and we can’t help but click. But why are we so hooked, and is there any real consensus on whether coffee is good for us?
Using lighter weights for strength training can build just as much muscle as the heavier iron, according to a growing pile of research. You just need to know how.
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results